Quest Diagnostics (DGX) Tops Q3 EPS by 58c, Raises FY Guidance
Get Alerts DGX Hot Sheet
Price: $135.32 -1.62%
Revenue Growth %: +1.7%
Financial Fact:
Net income: 1.34
Today's EPS Names:
FRSB, DGICA, UXIN, More
Revenue Growth %: +1.7%
Financial Fact:
Net income: 1.34
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Quest Diagnostics (NYSE: DGX) reported Q3 EPS of $4.31, $0.58 better than the analyst estimate of $3.73. Revenue for the quarter came in at $2.79 billion versus the consensus estimate of $2.73 billion.
GUIDANCE:
Quest Diagnostics sees FY2020 EPS of $9.00-$10.00, versus the consensus of $8.71. Quest Diagnostics sees FY2020 revenue of $8.8-9.1 billion, versus the consensus of $8.74 billion.
For earnings history and earnings-related data on Quest Diagnostics (DGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Quest Diagnostics (DGX) PT Raised to $150 at Truist Securities
- First Resource Bank (FRSB) Tops Q1 EPS by 43c
- Ladder Capital (LADR) Tops Q1 EPS by 4c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!